ULC therapy | RFVE therapy | ||||||
---|---|---|---|---|---|---|---|
n | Before | After | n | Before | After | ||
Overall | 113 | 41.1 ± 17.6 | 44.1 ± 17.3* | 263 | 41.7 ± 16.1 | 48.2 ± 15.2*† | |
Motor impairment | F-M UE score ≤ 20 | 19 | 11.1 ± 6.5 | 14.6 ± 8.5* | 35 | 11.8 ± 5.2 | 19.0 ± 9.0*† |
21 ≤ F-M UE score ≤ 40 | 29 | 32.5 ± 5.5 | 36.1 ± 6.8* | 72 | 32.2 ± 5.9 | 41.5 ± 7.6*† | |
F-M UE score > 40 | 65 | 53.8 ± 7.1 | 55.9 ± 8.1* | 156 | 52.7 ± 7.3 | 57.8 ± 6.4*† | |
Stroke to Rehabilitation Interval | ≤ 3months | 32 | 47.7 ±16.4 | 51.3 ± 15.2* | 68 | 44.9 ± 14.0 | 53.8 ± 11.5*† |
3 < months < 12 | 57 | 38.9 ± 17.5 | 41.7 ± 17.2* | 113 | 39.5 ± 17.2 | 46.0 ± 16.0*† | |
≥ 12 months | 24 | 37.7 ± 17.7 | 40.3 ± 18.0* | 82 | 41.8 ± 15.9 | 46.7 ± 15.7* |